相似文献
1
Diagnosis and management of telaprevir-associated rash.替拉那韦相关皮疹的诊断与管理
Gastroenterol Hepatol (N Y). 2011 Jul;7(7):469-71.
2
Incidence and Management of Rash in Telaprevir-Treated Patients.特拉匹韦治疗患者皮疹的发生率及处理
Ann Pharmacother. 2014 Sep;48(9):1166-1171. doi: 10.1177/1060028014539274. Epub 2014 Jun 17.
3
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.丙型肝炎及其治疗的皮肤学副作用：直接作用抗病毒药物时代的患者管理。
J Hepatol. 2012 Feb;56(2):455-63. doi: 10.1016/j.jhep.2011.08.006. Epub 2011 Aug 30.
4
[Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study].[特拉匹韦/聚乙二醇干扰素/利巴韦林治疗慢性丙型肝炎的皮肤不良事件：一项多中心前瞻性队列研究]
Ann Dermatol Venereol. 2016 May;143(5):336-46. doi: 10.1016/j.annder.2016.02.028. Epub 2016 May 6.
5
Drug rash with eosinophilia and systemic symptoms due to telaprevir.替拉瑞韦引起的伴有嗜酸性粒细胞增多和全身症状的药物皮疹。
Dermatology. 2010;221(4):303-5. doi: 10.1159/000318904. Epub 2010 Aug 25.
6
Telaprevir: a hepatitis C NS3/4A protease inhibitor.特拉匹韦：一种丙型肝炎 NS3/4A 蛋白酶抑制剂。
Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28.
7
A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms.替拉瑞韦罕见且严重的皮肤不良反应：药物疹伴嗜酸性粒细胞增多和全身症状。
G Ital Dermatol Venereol. 2019 Aug;154(4):488-491. doi: 10.23736/S0392-0488.17.05151-3.
8
Direct-acting antiviral-associated dermatitis during chronic hepatitis C virus treatment.直接作用抗病毒药物相关的丙型肝炎病毒治疗期皮疹。
Am J Clin Dermatol. 2013 Dec;14(6):497-502. doi: 10.1007/s40257-013-0035-7.
9
Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.替拉瑞韦：用于治疗基因 1 型慢性丙型肝炎的综述。
Drugs. 2012 Mar 26;72(5):619-41. doi: 10.2165/11208370-000000000-00000.
10
Cutaneous Eruption due to Telaprevir.特拉匹韦引起的皮肤疹
Case Rep Dermatol. 2015 Sep 29;7(3):253-62. doi: 10.1159/000439264. eCollection 2015 Sep-Dec.
引用本文的文献
1
Observational descriptive study of cutaneous manifestations in patients from Mato Grosso with viral chronic hepatitis.对来自马托格罗索州的病毒性慢性肝炎患者皮肤表现的观察性描述性研究。
An Bras Dermatol. 2015 Nov-Dec;90(6):828-35. doi: 10.1590/abd1806-4841.20153851.
2
Hepatitis C virus genetic variability and evolution.丙型肝炎病毒的基因变异性与进化
World J Hepatol. 2015 Apr 28;7(6):831-45. doi: 10.4254/wjh.v7.i6.831.
3
DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin.以聚乙二醇化干扰素α2a和利巴韦林治疗丙型肝炎病毒相关性炎症后肝硬化时出现的药物超敏反应伴嗜酸性粒细胞增多和系统症状综合征作为并发症。
Postepy Dermatol Alergol. 2014 Dec;31(6):401-4. doi: 10.5114/pdia.2014.40939. Epub 2014 Dec 3.
4
Treatment of hepatitis C virus infection in the future.未来丙型肝炎病毒感染的治疗。
Clin Transl Med. 2013 Apr 11;2(1):9. doi: 10.1186/2001-1326-2-9.
本文引用的文献
1
Telaprevir for retreatment of HCV infection.特拉匹韦治疗丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2417-28. doi: 10.1056/NEJMoa1013086.
2
Telaprevir for previously untreated chronic hepatitis C virus infection.替拉瑞韦治疗初治慢性丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
3
Drug rash with eosinophilia and systemic symptoms due to telaprevir.替拉瑞韦引起的伴有嗜酸性粒细胞增多和全身症状的药物皮疹。
Dermatology. 2010;221(4):303-5. doi: 10.1159/000318904. Epub 2010 Aug 25.
4
Telaprevir for previously treated chronic HCV infection.替拉瑞韦治疗既往治疗的慢性 HCV 感染。
N Engl J Med. 2010 Apr 8;362(14):1292-303. doi: 10.1056/NEJMoa0908014.
5
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.替拉瑞韦 - 一种新型抗丙型肝炎病毒蛋白酶抑制剂的疗效和安全性。
Expert Opin Investig Drugs. 2010 Jan;19(1):151-9. doi: 10.1517/13543780903501505.
6
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.聚乙二醇干扰素α-2b或α-2a联合利巴韦林用于治疗丙型肝炎感染。
N Engl J Med. 2009 Aug 6;361(6):580-93. doi: 10.1056/NEJMoa0808010. Epub 2009 Jul 22.
7
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.特拉匹韦与聚乙二醇干扰素联合或不联合利巴韦林用于慢性丙型肝炎病毒感染的治疗。
N Engl J Med. 2009 Apr 30;360(18):1839-50. doi: 10.1056/NEJMoa0807650.
8
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.特拉匹韦联合聚乙二醇干扰素和利巴韦林用于慢性丙型肝炎1型感染
N Engl J Med. 2009 Apr 30;360(18):1827-38. doi: 10.1056/NEJMoa0806104.
9
Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.替拉瑞韦、聚乙二醇干扰素α-2a和利巴韦林对丙型肝炎患者28天的抗病毒作用及安全性。
J Hepatol. 2008 Aug;49(2):163-9. doi: 10.1016/j.jhep.2008.03.027. Epub 2008 Apr 29.
Zotero 插件